Acquisitions (Tables)

6 Months Ended

Feb. 29, 2016

Acquisitions [Abstract]

Schedule of Impact of Equity Transaction

The impact of the equity transaction is as follows (in millions):

	Amount
Consideration attributable to WBAD	$	2,559
Less:  Carrying value of the Company’s pre-existing noncontrolling interest		130
Impact to additional paid in capital	$	2,429

Schedule of Business Acquisition Total Consideration Paid

Consideration paid

Cash	$	4,874
Common stock		10,977
Total consideration transferred		15,851
Less: consideration attributed to WBAD		(2,559	)
		13,292
Fair value of the investment in Alliance Boots held before the Second Step Transaction		8,149
Total consideration	$	21,441

Schedule of Identifiable Assets Acquired and Liabilities Assumed Including Noncontrolling Interests

Identifiable assets acquired and liabilities assumed including noncontrolling interests

 

Cash and cash equivalents	$	413
Accounts receivable		3,799
Inventories		3,713
Other current assets		894
Property, plant and equipment		3,806
Intangible assets		11,691
Other non-current assets		2,217
Trade accounts payable, accrued expenses and other liabilities		(7,696	)
Borrowings		(9,010	)
Deferred income taxes		(2,452	)
Other non-current liabilities		(383	)
Noncontrolling interests		(412	)
Total identifiable net assets and noncontrolling interests		6,580
Goodwill	$	14,861

Schedule of Identified Definite and Indefinite Lived Intangible Assets

The identified definite and indefinite lived intangible assets were as follows:

Definite-Lived Intangible Assets	Weighted-Average Useful Life (in years)	Amount (in millions)
Customer relationships	12	$	1,311
Loyalty card holders	20		742
Trade names and trademarks	9		399
Favorable lease interests	7		93
Total		$	2,545

Indefinite-Lived Intangible Assets	Amount (in millions)
Trade names and trademarks	$	6,657
Pharmacy licenses		2,489
Total	$	9,146

Schedule of Unaudited Pro Forma Results Prepared for Comparative Purposes

Accordingly, the unaudited condensed pro forma information has been prepared for comparative purposes only and is not intended to be indicative of what the Company’s results would have been had the Second Step Transaction occurred at the beginning of the periods presented or the results which may occur in the future.

	Pro forma Three Months Ended February 28, 2015		Pro forma Six Months Ended February 28, 2015
(in millions, except per share amounts)
Net sales	$	30,202	$	59,173
Net earnings		1,253		2,621
Net earnings per common share:
Basic	$	1.20	$	2.51
Diluted		1.19		2.49